CNBC Daily Open: UBS posts strong earnings while Novo Nordisk's U.S. shares crater on slowing growth

In this article

Taken from CNBC’s Daily Open, our international markets newsletter — Subscribe today

fourth-quarter profit rose 56% year on year to $1.2 billion, beating expectations. The Swiss bank on Wednesday also announced plans for a $3 billion share buyback in 2026 — but said it aims to exceed that target.

Danish pharmaceutical giant Novo Nordisk

, however, disappointed investors when it said Tuesday it expects sales and profit growth dropping this year. Following the surprise release — Novo was scheduled to announce results on Wednesday — Novo’s American depository shares fell more than 14%.